812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study
Jorge R. Kizer,Aud Høieggen,Michael H. Alderman,Sverre E. Kjeldsen,Björn Dahlöf,Stevo Julius,Gareth Beevers,Ulf de Faire,Frej Fyhrquist,Hans Ibsen,Krister Kristiansson,Ole Lederballe-Pedersen,Lars H Lindholm,Marku S Nieminen,Per Omvik,Suzanne Oparil,Hans Wedel,Jonathan M. Edelman,Steven M. Snapinn,Richard B. Devereux +19 more
TLDR
Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: the losartan intervention for endpoint reduction in hypertension.About:
This article is published in Journal of the American College of Cardiology.The article was published on 2004-03-01 and is currently open access. It has received 4 citations till now. The article focuses on the topics: Left ventricular hypertrophy & Losartan.read more
Citations
More filters
Journal ArticleDOI
Diagnostic Implications of Uric Acid in Electroanalytical Measurements
TL;DR: The present review has sought to rationalize the clinical importance that urate measurements could hold in future diagnostic applications - particularly within near patient testing contexts.
Journal ArticleDOI
A novel electrochemical biosensor for the detection of uric acid and adenine.
TL;DR: A novel electrochemical biosensor prepared based on a gel containing multi-walled carbon nanotubes and room-temperature ionic liquid of 1-octyl-3-methylimidazolium hexafluorophosphate can provide a simple and easy approach for sensitive detection of uric acid and adenine.
Journal Article
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
TL;DR: The efficacy, tolerability, and convenience of losartan/HCTZ combination therapy may increase patient compliance and lower risk for stroke, a devastating outcome in patients with hypertension.
Reference EntryDOI
Spherical and Anisotropic Copper Nanomaterials in Medical Diagnosis
TL;DR: This chapter first addresses the essential issues of Cun production, followed by the applications of C un in medical sciences organized by the key biomarkers related to disease processes.